127 related articles for article (PubMed ID: 32403994)
1. Primary leiomyosarcoma of the uterine cervix: report of 4 cases, systematic review, and meta-analysis.
Kiliç C; Yuksel D; Cakir C; Turkmen O; Kimyon Comert G; Başaran D; Turan T
Tumori; 2020 Oct; 106(5):413-423. PubMed ID: 32403994
[TBL] [Abstract][Full Text] [Related]
2. [Epithelioid leiomyosarcoma of the uterine cervix: two cases].
Chargui R; Bouzid T; Khomsil F; Damak T; Hassouna JB; Mtaallah M; Dhieb T; Gamoudi A; Boussen H; Hechiche M; Rahal K
Tunis Med; 2007 Nov; 85(11):963-6. PubMed ID: 19166150
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients.
Mancari R; Signorelli M; Gadducci A; Carinelli S; De Ponti E; Sesana S; Corso S; Chiappa V; Colombo N; Lissoni AA
Gynecol Oncol; 2014 Jun; 133(3):531-6. PubMed ID: 24631454
[TBL] [Abstract][Full Text] [Related]
4. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
Höckel M; Hentschel B; Horn LC
Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant management of operated uterine sarcomas: A single institution experience.
Cordoba A; Prades J; Basson L; Robin YM; Taïeb S; Narducci F; Hudry D; Bresson L; Chevalier A; Le Tinier F; Mirabel X; Lartigau É; Penel N; Leblanc É
Cancer Radiother; 2019 Sep; 23(5):401-407. PubMed ID: 31351809
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
Rosa DD; Medeiros LR; Edelweiss MI; Pohlmann PR; Stein AT
Cochrane Database Syst Rev; 2012 Jun; 6(6):CD005342. PubMed ID: 22696349
[TBL] [Abstract][Full Text] [Related]
7. Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience.
Sert BM; Kristensen GB; Kleppe A; Dørum A
Gynecol Oncol; 2021 Aug; 162(2):284-291. PubMed ID: 34083029
[TBL] [Abstract][Full Text] [Related]
8. Leiomyosarcoma of the cervix.
Irvin W; Presley A; Andersen W; Taylor P; Rice L
Gynecol Oncol; 2003 Dec; 91(3):636-42. PubMed ID: 14675691
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
10. The uncovered story of leiomyosarcoma of the cervix: a rare case report and review of literature.
Dhull AK; C A; Kaushal V; Marwah N
BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23519508
[TBL] [Abstract][Full Text] [Related]
11. Sarcomas and carcinosarcomas of the uterine cervix.
Abell MR; Ramirez JA
Cancer; 1973 May; 31(5):1176-92. PubMed ID: 4705156
[No Abstract] [Full Text] [Related]
12. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
Rosa DD; Medeiros LR; Edelweiss MI; Bozzetti MC; Pohlmann PR; Stein AT; Dickinson HO
Cochrane Database Syst Rev; 2009 Jul; (3):CD005342. PubMed ID: 19588370
[TBL] [Abstract][Full Text] [Related]
13. Tumor budding in cervical cancer as a prognostic factor and its possible role as an additional intermediate-risk factor.
Park JY; Chong GO; Park JY; Chung D; Lee YH; Lee HJ; Hong DG; Han HS; Lee YS
Gynecol Oncol; 2020 Oct; 159(1):157-163. PubMed ID: 32741542
[TBL] [Abstract][Full Text] [Related]
14. Leiomyosarcoma of the uterine cervix in a young woman.
Sahu L; Bupathy A; Badhe BA
J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):717-20. PubMed ID: 18840189
[TBL] [Abstract][Full Text] [Related]
15. Is Adjuvant Therapy Necessary for Patients with Intermediate-Risk Cervical Cancer after Open Radical Hysterectomy?
Yahata H; Sonoda K; Inoue S; Yasutake N; Kodama K; Yagi H; Yasunaga M; Ohgami T; Onoyama I; Kaneki E; Okugawa K; Asanoma K; Kato K
Oncology; 2020; 98(12):853-858. PubMed ID: 32683361
[TBL] [Abstract][Full Text] [Related]
16. Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2).
Akhavan S; Alibakhshi A; Parsapoor M; Alipour A; Rezayof E
BMC Cancer; 2021 Jun; 21(1):667. PubMed ID: 34088300
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary recurrence after radical hysterectomy for uterine cervical carcinoma.
Kilic C; Yuksel D; Cakir C; Karalok A; Boyraz G; Moraloglu Tekin O; Turan T
J Obstet Gynaecol; 2020 Nov; 40(8):1155-1159. PubMed ID: 32027187
[TBL] [Abstract][Full Text] [Related]
18. Radical hysterectomy compared with primary radiation for treatment of stage IB1 cervix cancer.
Doll KM; Donnelly E; Helenowski I; Rosenbloom L; Small W; Schink JC; Lurain JR
Am J Clin Oncol; 2014 Feb; 37(1):30-4. PubMed ID: 22992622
[TBL] [Abstract][Full Text] [Related]
19. Leiomyosarcoma of cervical stump following subtotal hysterectomy: a case report and review of literature.
Zhiqiang L; Bin S; Min F; Yufang L
Eur J Gynaecol Oncol; 2016; 37(1):148-51. PubMed ID: 27048131
[TBL] [Abstract][Full Text] [Related]
20. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
